Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Afterpay (ASX:APT) Plans To Boost Its Share Price By Conquering Health Care

Afterpay Touch Group Ltd (ASX:APT) has a plan to conquer the healthcare market and boost its share price further. 

Afterpay Touch Group Ltd (ASX: APT) has a plan to conquer the healthcare market and boost its share price further.

Afterpay Touch is the owner of the popular “buy now, pay later” app. As of early 2019, Afterpay had over 4 million registered users worldwide, making it one of Australia’s true technology success stories.

Afterpay’s Health Care Plan

The leading buy now, pay later company plans to expand significantly into the health care arena. Pharmacies, GP clinics and radiology will soon be places where the service can be used according to the Sydney Morning Herald.

Afterpay has already rolled out to optometrists and dentists over the past year, so it would make sense to go to health care providers that don’t bulk bill.

One of the main reasons that Afterpay sees a potential benefit from making this expansion is that a growing number of people are ending their private health insurance, but may still want assistance in paying for the health care service, such as splitting up the payments.

The SMH quoted Afterpay’s Head of Healthcare Mathew Cagney, “With more than 11 million Australians not having access to ‘Extras’ cover, we are meeting a genuine need – and for those that do have cover, there is nearly always going to be a gap payment that needs to be made.”

Does This Make Afterpay A Buy?

Every time that Afterpay can increase its total addressable market (TAM) it increases the growth potential and the number of merchants that it can earn a fee from.

For a country that tries to provide a high level of public health cover, I’m not sure that growth of Afterpay in this area is a particularly positive thing, as it would suggest healthcare is moving towards being unaffordable for more people. I wouldn’t want to see the Australian healthcare system start moving towards the American one. But, it is a clever move by Afterpay.

But, at the current Afterpay price, I would much rather invest in the growth shares in the free report below.

[ls_content_block id=”18457″ para=”paragraphs”]

[ls_content_block id=”18380″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content